C. Crépin

463 total citations
7 papers, 349 citations indexed

About

C. Crépin is a scholar working on Genetics, Cancer Research and Dermatology. According to data from OpenAlex, C. Crépin has authored 7 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 2 papers in Cancer Research and 1 paper in Dermatology. Recurrent topics in C. Crépin's work include BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (2 papers) and Allergic Rhinitis and Sensitization (1 paper). C. Crépin is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (2 papers) and Allergic Rhinitis and Sensitization (1 paper). C. Crépin collaborates with scholars based in Netherlands, United States and Luxembourg. C. Crépin's co-authors include Madeleine M.A. Tilanus‐Linthorst, Caroline Seynaeve, J.G.M. Klijn, Cecile T.M. Brekelmans, C.C.M. Bartels, A.N. van Geel, A. van den Ouweland, Inge-Marie Obdeijn, Marcel N. Menke and E.J. Meijers-Heijboer and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Revue française d'allergologie.

In The Last Decade

C. Crépin

7 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Crépin Netherlands 4 269 150 115 103 66 7 349
Anita Vabø Norway 7 197 0.7× 102 0.7× 86 0.7× 80 0.8× 58 0.9× 7 343
Joellen Schildkraut United States 6 270 1.0× 144 1.0× 121 1.1× 153 1.5× 126 1.9× 12 464
Clelia de Giacomi Italy 7 163 0.6× 131 0.9× 154 1.3× 161 1.6× 69 1.0× 8 447
Mateja Krajc Slovenia 11 203 0.8× 58 0.4× 66 0.6× 73 0.7× 123 1.9× 47 308
Inge‐Marie Obdeijn Netherlands 7 137 0.5× 144 1.0× 159 1.4× 110 1.1× 29 0.4× 7 368
Elke M. van Veen United Kingdom 11 272 1.0× 99 0.7× 51 0.4× 167 1.6× 112 1.7× 24 440
Neal Clark Norway 9 232 0.9× 120 0.8× 126 1.1× 104 1.0× 83 1.3× 12 352
Woo-Chul Noh South Korea 8 117 0.4× 173 1.2× 140 1.2× 86 0.8× 111 1.7× 18 383
Molly Sebastian United States 4 169 0.6× 134 0.9× 78 0.7× 76 0.7× 54 0.8× 9 263
Isabella Marchi Italy 11 188 0.7× 88 0.6× 46 0.4× 119 1.2× 90 1.4× 17 269

Countries citing papers authored by C. Crépin

Since Specialization
Citations

This map shows the geographic impact of C. Crépin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Crépin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Crépin more than expected).

Fields of papers citing papers by C. Crépin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Crépin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Crépin. The network helps show where C. Crépin may publish in the future.

Co-authorship network of co-authors of C. Crépin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Crépin. A scholar is included among the top collaborators of C. Crépin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Crépin. C. Crépin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Brekelmans, Cecile T.M., Caroline Seynaeve, M. Menke-Pluymers, et al.. (2005). Survival and prognostic factors in BRCA1-associated breast cancer. Annals of Oncology. 17(3). 391–400. 101 indexed citations
3.
Klijn, J.G.M., A.N. van Geel, Hanne Meijers-Heijboer, et al.. (2004). Long-term follow-up of the Rotterdam study on prophylactic mastectomy versus surveillance in BRCA1/2 mutation carriers. Journal of Clinical Oncology. 22(14_suppl). 9502–9502. 2 indexed citations
4.
Seynaeve, Caroline, Madeleine M.A. Tilanus‐Linthorst, Hanne Meijers-Heijboer, et al.. (2004). BRCA1- versus non-BRCA1/2-associated breast cancer (BC): Tumor characteristics and impact of prognostic and treatment factors. Journal of Clinical Oncology. 22(14_suppl). 9557–9557. 1 indexed citations
5.
Seynaeve, Caroline, Madeleine M.A. Tilanus‐Linthorst, Hanne Meijers-Heijboer, et al.. (2004). BRCA1- versus non-BRCA1/2-associated breast cancer (BC): Tumor characteristics and impact of prognostic and treatment factors. Journal of Clinical Oncology. 22(14_suppl). 9557–9557. 1 indexed citations
6.
Klijn, J.G.M., A.N. van Geel, Hanne Meijers-Heijboer, et al.. (2004). Long-term follow-up of the Rotterdam study on prophylactic mastectomy versus surveillance in BRCA1/2 mutation carriers. Journal of Clinical Oncology. 22(14_suppl). 9502–9502. 7 indexed citations
7.
Brekelmans, Cecile T.M., Caroline Seynaeve, C.C.M. Bartels, et al.. (2001). Effectiveness of Breast Cancer Surveillance in BRCA1/2 Gene Mutation Carriers and Women With High Familial Risk. Journal of Clinical Oncology. 19(4). 924–930. 233 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026